Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001

Sell:$18.93Buy:$18.94$0.13 (0.68%)

NASDAQ:2.78%
Market closed | Prices delayed by at least 15 minutes
Sell:$18.93
Buy:$18.94
Change:$0.13 (0.68%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$18.93
Buy:$18.94
Change:$0.13 (0.68%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 14 clinical-stage investigational medicines (nine wholly owned and five partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MUC5AC, ARO-MMP7, GSK-4532990, Fazirsiran, JNJ-3989, HZN-457, ARO-C3, ARO-PNPLA3, ARO-DUX4 and ARO-SOD1.

Key people

Christopher Richard Anzalone
Chairman of the Board, President, Chief Executive Officer
Kenneth Allen Myszkowski
Chief Financial Officer
Patrick C. O'Brien
Chief Operating Officer, General Counsel, Company Secretary
James Hamilton
Chief of Discovery and Translational Medicine
William D. Waddill
Lead Independent Director
Mauro Ferrari
Independent Director
Douglas S. Ingram
Independent Director
Hongbo B. Lu
Independent Director
Adeoye Y. Olukotun
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US04280A1007
  • Market cap
    $2.46bn
  • Employees
    609
  • Shares in issue
    126.10m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.